A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence.

John P F A HeesakkersPhilip Toozs-HobsonSuzette E SutherlandGiuseppe Alessandro DigesuCindy L AmundsenRebecca J McCreryStephan de WachterEmily R KeanFrank M J MartensKevin BensonKimberly L FerranteKevin J ClineOsvaldo F PadronLaura GiustoFelicia L LaneRoger R Dmochowski

Published in: Neurourology and urodynamics (2024)

iTNM, delivered and powered by a patient-controlled external wearable communicating with an implant, demonstrated clinically meaningful and statistically significant improvement in UUI symptoms and a high safety profile. This therapy highlights the value of patient-centric therapy for the treatment of UUI.

Keyphrases

urinary incontinence
case report
stem cells
physical activity
bone marrow
soft tissue
mesenchymal stem cells
replacement therapy
cell therapy